Clinical Trials Patient Experience Summit



Similar documents
What Lies Ahead? Trends to Watch: Health Care Product Development in North America

How To Understand And Understand Biosimilars

DAY 1 MONDAY, SEPT

In the largest and perhaps the most ambitious collaborative

Big Data Analytics Driving Healthcare Transformation

Technology and Expertise Add Operational Value to Medical Device Trials

OME : Mobile Cognitive Healthcare for the Consumer. Michael Nova, M.D. Chief Innovation Officer Pathway Genomics

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY

Big Data Analytics- Innovations at the Edge

Healthcare Challenges and Trends The Patient at the Heart of Care

Preparing a New Dermatologic Agent for Market Launch. March, 2011

Access. Action. Insight. Healthcare Analytics and Marketing Communications Consultative, Analytical, and Promotional Solutions

The registry of the future: Leveraging EHR and patient data to drive better outcomes

Big Data for Patients (BD4P) Stakeholder Engagement Plan

BEST PRACTICES RESEARCH

MAY 12-13, SAN FRANCISCO, CA MEET OUR MEMBER COMPANIES ON THE EXPO FLOOR

The Role of the Patient/Consumer in Establishing a Dynamic Clinical Research Continuum:

Accountable Care: Clinical Integration is the Foundation

Internet of Things and insurance. Paris, March 24h, 2015

Orphan Pharma: pathfinders for an increasingly specialised industry

The Cornerstones of Accountable Care ACO

Main Conference Agenda

Clinical Trials Need More Subjects

5 Key Trends in Connected Health

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014

Best Practices in Patient Navigation and Cancer Survivorship Survey Results

The Case for an External Digital Strategy For Payers

EPOCRATES 2013 MOBILE TRENDS REPORT. Maximizing Multi-Screen Engagement Among Clinicians

Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management

Measuring Health System Performance Population Health Analytics for Accountable Care PART 2 WHITE PAPER

Duke University Health System Electronic Health Record Update. Art Glasgow Chief Information Officer, Duke Medicine

5 th Global Mining IT & Communication Summit 4-5 November 2015 Toronto, Canada

SOCIAL MEDIA LISTENING AND ANALYSIS Spring 2014

THE BIOTECH & PHARMACEUTICAL INDUSTRY

HOAG FAMILY CANCER INSTITUTE. Case for Support

FWD. What the Internet of Things will mean for business

DIGITAL ENTERPRISE TRANSFORMATION (DET) SUMMIT, 2015

CLINICAL DEVELOPMENT OPTIMIZATION

Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification

Engaging E-Patients in Clinical Trials through Social Media. Patient Recruitment and the E-Patient: A Survey Analysis

Make Analytics Pervasive in Your Organization

Telemedicine Offers Growth for Hospitals, Rural Care Opportunities

Analytics and Business Intelligence

Cloud Marketing: Faces in the Cloud

Patient Advocacy. An emerging role within pharma and biotechnology. White Paper Presented by BioNJ and Merrill DataSite

Engaging Clinical Trial Sites:

Great Expectations: Why Pharma Companies Can t Ignore Patient Services

Advances, Opportunities and Innovative Solutions for Consumer and Clinical Wireless Medical Devices

Accelerating Clinical Trials Through Shared Access to Patient Records

10 Key Concepts for Higher Sales into ACOs

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

Population Health for Pharma: Perspectives from Aetna/Healthagen

Patient-Generated Health Data and its Impact on Health Information Management

Building Infrastructure to Enable the Digital Enterprise

Telehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs

The Rising Tide of Pharmacy Benefit Cost and Complexity: A health plans roadmap to optimizing pharmacy services relationships

Is Your Digital Health Strategy Thriving, Surviving or Non-Existent?

Guidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products

Ask Us About Clinical Trials

The Digital Imperative in Healthcare. Presented by Dr. Jay Patel, Principal from The Boston Consulting Group

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM Alliance. Innovation PRELIMINARY. Management

JHSPH - Inovalon, Inc. Information Session

How To Understand The Power Of The Internet Of Things

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision

Uncovering Value in Healthcare Data with Cognitive Analytics. Christine Livingston, Perficient Ken Dugan, IBM

Evolution of a Closed Loop Medication Use Process

SOCIAL MEDIA LISTENING AND ANALYSIS Spring 2014

Transforming CliniCal Trials: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions

The New World of Data. Don Strickland President, Strickland & Associates

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute

TOP 10 TRENDS FOR 2016 BUSINESS INTELLIGENCE

The Impact Of Employer Contribution Policy On Premium Rate Setting. Group-Specific Experience: Financial And Utilization Performance

Is Your System Ready for Population Health Management? By Dale J. Block, MD, CPE

Big Data and Real World Evidence

Session 4: Understanding Data Behind the Complex New World of Health Care Involving IDNs and ACOs. Laura Jenkins Jirele

Transcription:

Clinical Trials Patient Experience Summit How Connected Patient-Driven Initiatives are Improving Clinical Trial Productivity April 7-8, 2016 Sheraton Palo Alto Palo Alto, CA Day One, April 7 th 8:00 8:50 am Conference Registration Open (Cypress Ballroom Foyer) 9:00 9:10 am Opening Remarks from Conference Chairman Victor Morrison, Next IT 9:10 9:50 am KEYNOTE PANEL Clinical Trials & the Patient Experience At no other time have we had greater access to our own personal health data. Big data, the cloud, and eventual interoperability will enable us to gather, store and connect data in new ways. So what does it mean for the pharmaceutical and clinical trial industry how can that lead to an improved experience for patients? Kathy Vandebelt, Global Head, Clinical Innovation, Lilly Alicyn Campbell, Global Head, Patient-Centric Outcomes Research for Oncology, Genentech Drew Schiller, Co-Founder, CTO, Validic 9:50 10:20 am Game of Trials: Prepare for the End of CROs when you Least Expected it Today, the digital connection between market research and bringing therapies to market is missing. Deep understanding and experience with digitally enhanced therapies or digital therapeutics is absent at many clinical research organizations. Digital Outcomes Research (DOR) and the Internet of Things (IoT) are poised to break these adoption barriers. Many CROs will not survive the transition. The potential to accelerate both speed and cost of clinical trials will require collaboration between academic institutions, pharmaceutical companies, medical device and sensor companies, payers and providers to reach new heights. Such collaboration is only possible if study models that focus on what works for patients are embraced. Ahmed Albaiti, CEO, Medullan

10:20 10:55 am LILLY CASE STUDY: Crafting a New Clinical Research Ecosystem around the Most Important Human The Patient How does the industry need to change? What should drug developers consider when making the commitment to patient-centricity? Where is Lilly actively working to digitize the clinical development ecosystem? What does this mean for patients and healthcare providers? Kathy Vandebelt, Global Head, Clinical Innovation, Lilly 10:55 11:15 am Networking Break in Exhibition / Networking Area (Cypress Ballroom) 11:15 11:45 pm GENENTECH CASE STUDY: Advancing Development and Use of Patient-Reported Outcomes in Drug Development How to utilize patient feedback for making existing PRO tools as userfriendly as possible Near term opportunities for Genentech to engage patients on their terms What s next? Alicyn Campbell, Global Head, Patient-Centric Outcomes, Genentech 11:45 12:15 pm Bridging the Communication Gap: Helping HCPs Help Patients HCPs and patients recognize an effective doctor-patient communication as essential to high quality medical care. Learn how providing specialized virtual health assistants deliver a competitive advantage by enabling 24/7 information sharing with customers to efficiently improve adherence and unify care. Victor Morrison, SVP, NextIT Healthcare 12:15 12:45 FDA CASE STUDY: How Patient-Centered Drug Development Initiatives are being put at the forefront of guidelines The FDA's Patient-Focused Drug Development initiative is a commitment under the fifth authorization of the Prescription Drug User Fee Act (PDUFA V) that aims to more systematically gather patients perspectives on their condition and available therapies to treat their condition.

How these collaborations will enhance the voice of the patient in all aspects of the clinical development process Learn about how the FDA aims to better understand patients experience with symptoms, impacts on daily living, and available therapies Pujita Vaidya, Patient-Focused Drug Development Analyst, FDA 12:45 2:00 pm Executive Networking Luncheon Cypress Ballroom 2:00 2:30 pm ABBOTT CASE STUDY: Successfully Recruiting for Inpatient Studies Recruitment for clinical studies can be very challenging. This presentation will explore various recruitment strategies based on a 3 year oral nutritional supplement inpatient study conducted at 119 sites across the US and PR Hear a case study from Abbott Nutrition; what worked? What didn t work? Sonja Acosta, Sr. Clinical Research Associate, Abbott Laboratories 2:30 3:00 pm Generating Clinical Evidence for mhealth Solutions with Digitally- Enabled Health Outcomes Studies Patient receptivity to medical interventions is driven by both biological and behavioral factors. With the advent of digital tools such as wearables, connected devices, and smartphone apps, we are able to collect new types of behavioral data and characterize patient's behavioral patterns. Understanding how these behavioral patterns tie to health outcomes is critical to optimizing patient outcomes. At Evidation Health, we have analyzed a large dataset that includes both medical claims data and patient behavior data to uncover these relationships. We'll present some representative findings and discuss how they can be utilized by pharmaceutical companies in research and commercial efforts. Jesse Juusola Head of Outcomes Research Evidation Health 3:00 3:30 pm CTTI CASE STUDY: Effective Engagement with Patient Groups around Clinical Trials With the increasing commitment to Patient-Focused Drug Development (PFDD) by FDA and patient engagement in translational research, there is a significant opportunity to improve the clinical trials enterprise and enhance participation by patient groups in the work of trial sponsors. PFDD and patient engagement in research should be considered an effort to extend

the benefits of incorporating patient insight and experiences, as well as desires and preferences, from bench to bedside and back. Sharon Hesterlee, Chief Science Officer, Myotonic Dystrophy Foundation 3:30 3:50 pm Networking Break in Pre-Function Foyer 3:50 4:10 pm How Innovation at Roche is leading to Better Education for Patients in Clinical Trials Hear how Roche/Genentech is dedicating resources around digital experience to improve patient education and understand why this is important for improving patient relations Discover how patient recruitment and retention can be improved with better educational resources in a digital world Nariman Nasser, Digital Strategist, Operational Innovation, Roche 4:10 5:00 pm STARTUP PANEL: Hear from the latest tech companies leadership on their challenges in implementation and outreach Hear from top innovators who are leading the charge on improving the patient experience Understand their concerns and hurdles that they must overcome from FDA and gain support within organizations Moderated by Shannon Bergstedt, Evidation Health Engaging Patients to Gather Medical Record Data 1. Medical record data is so vital to the trial process, but current solutions don't work. 2. To engage patients, give them something of real value - access to all their records. 3. Bring consumer tech insights to patient experience. 4. Applications across the drug development lifecycle. Noga Leviner, CEO, Picnic Health Technology for Early Detection How can it be applied to Clinical Trials? 1. Transferring Wearables From Fitness to Personalized Healthcare Through Individual Breast Cancer Screening 2. Innovative, Personal Early Breast Wellness Screening 3. What have we learned? Rob Royea, CEO, Cyrcadia The Last Healthcare Frontier The Patient 1. P-MAR - Patient Med Adminstration Record 2. PGHD Patient-Generated Health Data Naveen Khan, CEO, PT Pal 5:00 6:30 pm Networking Drinks Reception in Cypress Hall 6:45 pm End of Day One

Day Two, April 8th 8:00 9:00 am Day Two Registration Open 9:00 9:10 am Chairman s Day One Recap and Opening Remarks Ben Lei, Evidation Health 9:10 9:35 am GSK CASE STUDY: Voice of the Patient in Safety Social media medication discussions; what are patients saying? Who is posting on social media about medications? What it means for patient safety activities at one global pharmaceutical company Michele Thomas, Director of Safety Innovation, GlaxoSmithKline 9:35 10:00 am The Starting Line - Leveraging Smart Technologies to Help People Become and Stay Healthier Promoting and sustaining positive behaviors to become lifestyle changes is a serious challenge. We will explore AI, IT, medical devices and other technologies that we can leverage to help people add years to their lives and life to their years. Greg Caressi, SVP, Healthcare & Life Sciences, Frost & Sullivan 10:00 10:40 am KEYNOTE PANEL: Digital Trial & Error: The Evolution of Clinical Trials Recruitment Experience Overview of the evolution of clinical trials recruitment and retention considerations around patient journals, monitoring, site visits, data handling & privacy How pharma, CROs and other research organizations are utilizing social media and other strategies to improve their targeting and understanding of recruitment How can patient engagement can create a better relationship and improve patient recruitment & retention Meghan McKenzie, Sr. Clinical Program Lead, Genentech Sonja Acosta, Sr. Clinical Research Associate, Abbott Rajesh Menon, Sr. Clinical Research Associate, Genentech Moderated by Ben Lei, Evidation Health 10:40 11:00 am Using Technology to Collect Standardized, Reliable and Clinically Meaningful Patient Data

Leveraging technology to develop effective measurement tools Empowering patients to self report quantitative data Creating efficiencies and improving the consistency of clinical data collection across sites Navigating the development map for Software as a MedDevice Drew Schiller, Co-Founder, CTO, Validic 11:00 11:20 am Networking Break in Pre-Function Foyer (Cypress Ballroom) 11:20 11:50 am MEDABLE The App and Analytics Platform for Healthcare Michelle Longmire, CEO, Medable 11:50 12:20 pm Revolutionizing Clinical Trials: How Pharma Clinical Trials can become more Patient-Centric Patient knowledge is an evolving area and hidden opportunity for clinical development How to design a patient-centric study Leveraging existing social networks for patient connections and insights; lessons learned How do we get to patients earlier than we ever have before? Meghan McKenzie, Sr. Clinical Program Lead, Genentech 12:20 12:40 pm CenterWatch: Helping Patients Connect with Clinical Trials At CenterWatch, our mission is to be the leading source of clinical trials information for both clinical research professionals and patients. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates. Today, we have one of the largest clinical trial databases actively seeking patients on the Internet. Joan Chambers, COO, CenterWatch 12:40 1:15pm Evaluating the Utility of Wearable Technology in Oncology Care Cooperative research between FitBit and clinical oncology group program at Cedars-Sinai Overview of Study: Activity tracking Oncology Wearables and Reporting System o Background & purpose o Basic research plan

o Discussion clinical application Clinical Perspective Behavioral Medicine goals for improvement of patient treatment experience, quality of life, treatment adherence, communication with medical team Scientific & Business Perspective timeliness of wearable technology research in healthcare Arvind Shinde, MD, Oncology Supportive Care, Cedars-Sinai 1:15 2:30 pm Executive Networking Luncheon Cypress Ballroom 3:00 pm End of Conference